Doctors are driving without gauges and running on empty…

Care variance and high costs are widespread, but doctors haven’t been given any tools to help them make better decisions.

CareGauge gives physicians a real-time view of how their care decisions for a particular patient compare to locally benchmarked patients with that same condition.

Physicians can see cost and care utilization insights on length of stay, imaging, labs, medications, procedures, and more to help them deliver the best care to their patients.

How does it work?

• Integrate seamlessly into your EHR
• Source and analyze treatment and cost data from your facility
• Present instant insight into care decisions
• Empower physicians to provide the best value of care

EvidenceCare is a unique type of clinical decision support system (CDSS) with its EHR-integrated and content-agnostic platform that empowers better care decisions by improving clinical workflows.

Founded in response to the professional experience of emergency physician Dr. Brian Fengler, the platform provides clinicians with evidence-based insights and measurable outcomes that improve hospital margins.

Based in Nashville, Tennessee, EvidenceCare is a 2x honoree of the INC 5000 list of fastest growing companies, a 2x Fierce Healthcare Best Product winner, and one of Modern Healthcare's Best Places to Work in Healthcare.

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

Doctors can't change their clinical decisions after they're done with their patient interactions. Real-time integration in the EHR allows decisions to be made at the point of care.

Real-time utilization insights as opposed to all others which are focused on retrospective reporting

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement